Home
Conditions
Neoplasms, Plasma Cell

Clinical trial condition

Neoplasms, Plasma Cell

Explore clinical trials studying Neoplasms, Plasma Cell. Study availability and eligibility vary by location and protocol.

512 public trials 52 recruiting studies

Refine in advanced search Browse all conditions

Neoplasms, Plasma Cell trial results

Recruiting

Safety and Efficacy of APRIL-BAFF-Bicephali CAR-T in Relapsed, Refractory Multiple Myeloma

NCT06132711

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Kailin Xu Xuzhou, Jiangsu, China

View Trial Details

Recruiting

A Study to Investigate Safety and Clinical Activity of Belantamab Mafodotin in Combination With Lenalidomide, Dexamethasone and Nirogacestat in Patients With Transplant Ineligible Newly Diagnosed Multiple Myeloma

NCT05573802

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Corneal Disease, +18 more
Locations: General Hospital of Athens "Alexandra", NKUA, Therapeutic Clinic Athens, Greece

Anticancer Hospital of Thessaloniki "Theageneio" Thessaloniki, Greece

View Trial Details

Enrolling by Invitation

AI-Based Fine Morphological Subtyping of Myeloma Single Cells for Predicting FISH Abnormalities

NCT07410403

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Zhongnan Hospital of Wuhan University Wuhan, Hubei, China

View Trial Details

Enrolling by Invitation

ASH Research Collaborative Data Hub

NCT05775224

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +20 more
Locations: ASH Research Collaborative Washington D.C., District of Columbia, United States

View Trial Details

Not Yet Recruiting

Rutgers University Study of the Genetics of Blood Cancers

NCT07714044

Conditions: Blood Cancer, Blood Cancers, Hematologic Cancer, +17 more
Locations: Rutgers University Piscataway, New Jersey, United States

View Trial Details

Not Yet Recruiting

Delayed Toxicities Post-CAR-T

NCT07665307

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chemically-Induced Disorders, +16 more
Locations: UCSF Medical Center San Francisco, California, United States

Mount Sinai New York, United States

Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Not Yet Recruiting

Etenta-Isa-VRd in Newly Diagnosed High-Risk Multiple Myeloma

NCT07600151

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: University Medical Center Hamburg-Eppendorf Hamburg, Germany

View Trial Details

Not Yet Recruiting

In Vivo BCMA/GPRC5D Tandem Dual CAR-T Therapy for Relapsed/Refractory Plasma Cell Neoplasms

NCT07586709

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Plasma Cell, +1 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

REal World MAIA UK OutcomEs

NCT07532473

Conditions: Myeloma, Neoplasms, Neoplasms by Histologic Type, +1 more
Locations: The Royal Wolverhampton NHS Trust Wolverhampton, United Kingdom

View Trial Details

Not Yet Recruiting

CAR19BCMA CAR-T Cells for the Treatment of R/R Plasma Cell Neoplasms and Lymphomas/Leukemias With Plasmacytic Differentiation

NCT06986434

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: the Fifth Medical Center of Chinese People's Liberation Army General Hospital Beijing, China

View Trial Details

Neoplasms, Plasma Cell

Neoplasms, Plasma Cell trial results

Related conditions